The effect of Remifentanil and Apotel in pain control of patients undergoing laparotomy

Phase 3

• Conditions: Postoperative Pain.; Acute pain, not elsewhere classified; G89.1

• Registration Number: IRCT20191104045328N24
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 26 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Candidates for emergency laparotomy include cancer of abdominal organs, peritonitis, appendicitis, pancreatitis, abscess, adhesions (after trauma or surgery), diverticulitis, intestinal perforation or obstruction, foreign bodies and internal bleeding in accessible spaces.
Aged 18 to 65 years
Consent of the participants to participate in the study

Exclusion Criteria

Addiction to any drug
Known hypersensitivity to remifentanil or Apotel
Complicated laparotomy
Laparotomy with long unconventional time
Wound infection

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Intensity of pain. Timepoint: Immediately after consciousness, 1 hour later, 3 hours later, 8 hours later and finally 24 hours after surgery. Method of measurement: Visual analog scale.;Taking additional painkillers. Timepoint: Within 24 hours after surgery. Method of measurement: History.;Side effects. Timepoint: during operation. Method of measurement: History.